Search

Carla J. Myers

Examiner (ID: 16755, Phone: (571)272-0747 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1621, 1655, 1644, 1643, 1807, 1654, 1682, 1609
Total Applications
2297
Issued Applications
991
Pending Applications
343
Abandoned Applications
982

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18280753 [patent_doc_number] => 20230096225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => CLINICAL PREDICTORS OF WEIGHT LOSS [patent_app_type] => utility [patent_app_number] => 17/581335 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581335 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581335
CLINICAL PREDICTORS OF WEIGHT LOSS Jan 20, 2022 Abandoned
Array ( [id] => 17673147 [patent_doc_number] => 20220186314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE [patent_app_type] => utility [patent_app_number] => 17/580357 [patent_app_country] => US [patent_app_date] => 2022-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580357 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/580357
METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE Jan 19, 2022 Abandoned
Array ( [id] => 17982976 [patent_doc_number] => 20220349012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/561434 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/561434
DNA METHYLATION DIAGNOSTIC TEST FOR BREAST CANCER Dec 22, 2021 Abandoned
Array ( [id] => 18972329 [patent_doc_number] => 20240052421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS [patent_app_type] => utility [patent_app_number] => 18/259067 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259067 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/259067
METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS Dec 21, 2021 Pending
Array ( [id] => 17688216 [patent_doc_number] => 20220195508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease [patent_app_type] => utility [patent_app_number] => 17/554782 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/554782
tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease Dec 16, 2021 Pending
Array ( [id] => 17520796 [patent_doc_number] => 20220106645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => Biomarkers for the Diagnosis of Lung Cancers [patent_app_type] => utility [patent_app_number] => 17/551113 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/551113
Biomarkers for the Diagnosis of Lung Cancers Dec 13, 2021 Abandoned
Array ( [id] => 19121242 [patent_doc_number] => 11965213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Methods of detecting spatial heterogeneity of a biological sample [patent_app_type] => utility [patent_app_number] => 17/538406 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 52 [patent_no_of_words] => 104474 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 303 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538406 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/538406
Methods of detecting spatial heterogeneity of a biological sample Nov 29, 2021 Issued
Array ( [id] => 18879574 [patent_doc_number] => 20240002943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => A METHOD FOR CLASSIFYING THE GUT INFLAMMATION STATUS IN AVIAN SPECIES [patent_app_type] => utility [patent_app_number] => 18/265029 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7399 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265029 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265029
A METHOD FOR CLASSIFYING THE GUT INFLAMMATION STATUS IN AVIAN SPECIES Nov 21, 2021 Pending
Array ( [id] => 19826493 [patent_doc_number] => 12247259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Using nucleic acid size range for noninvasive cancer detection [patent_app_type] => utility [patent_app_number] => 17/521333 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 24 [patent_no_of_words] => 21654 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/521333
Using nucleic acid size range for noninvasive cancer detection Nov 7, 2021 Issued
Array ( [id] => 18955601 [patent_doc_number] => 20240043928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => BIOMARKERS FOR MYELODYSPLASTIC SYNDROME (MDS) AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/034859 [patent_app_country] => US [patent_app_date] => 2021-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034859 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/034859
BIOMARKERS FOR MYELODYSPLASTIC SYNDROME (MDS) AND METHODS OF USING THE SAME Nov 2, 2021 Pending
Array ( [id] => 17414415 [patent_doc_number] => 20220049319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => METHODS FOR DETECTING AND TREATING PROPRANOLOL SENSITIVE TUMORS [patent_app_type] => utility [patent_app_number] => 17/513279 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513279 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/513279
Methods for detecting and treating propranolol sensitive tumors Oct 27, 2021 Issued
Array ( [id] => 18903107 [patent_doc_number] => 20240018592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS [patent_app_type] => utility [patent_app_number] => 18/033582 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033582 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/033582
METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS Oct 25, 2021 Pending
Array ( [id] => 17402673 [patent_doc_number] => 20220044764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => TREATMENT OF CANCER BY RISK STRATIFICATION OF PATIENTS BASED ON COMORDIDITIES [patent_app_type] => utility [patent_app_number] => 17/451482 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13940 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451482 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/451482
TREATMENT OF CANCER BY RISK STRATIFICATION OF PATIENTS BASED ON COMORDIDITIES Oct 18, 2021 Abandoned
Array ( [id] => 17367697 [patent_doc_number] => 20220022749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => ALZHEIMER'S DISEASE PERSONALIZED MEDICINE [patent_app_type] => utility [patent_app_number] => 17/499060 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499060 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/499060
ALZHEIMER'S DISEASE PERSONALIZED MEDICINE Oct 11, 2021 Abandoned
Array ( [id] => 18786465 [patent_doc_number] => 20230374591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/030801 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18889 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030801 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030801
METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS Oct 6, 2021 Pending
Array ( [id] => 17705037 [patent_doc_number] => 20220205043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => DETECTING CANCER RISK [patent_app_type] => utility [patent_app_number] => 17/493826 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493826 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493826
Detecting cancer risk Oct 3, 2021 Issued
Array ( [id] => 18270796 [patent_doc_number] => 20230092038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => DRAIN FLUID FOR DIAGNOSTICS [patent_app_type] => utility [patent_app_number] => 17/491237 [patent_app_country] => US [patent_app_date] => 2021-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491237 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/491237
Drain fluid for diagnostics Sep 29, 2021 Issued
Array ( [id] => 17444212 [patent_doc_number] => 20220064717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => RNA Printing and Sequencing Devices, Methods, and Systems [patent_app_type] => utility [patent_app_number] => 17/480839 [patent_app_country] => US [patent_app_date] => 2021-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15986 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480839 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/480839
RNA Printing and Sequencing Devices, Methods, and Systems Sep 20, 2021 Pending
Array ( [id] => 19676244 [patent_doc_number] => 12188095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-07 [patent_title] => Methods and compositions for identifying and treating patients with small cell lung cancer [patent_app_type] => utility [patent_app_number] => 17/479701 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 98 [patent_no_of_words] => 28688 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479701
Methods and compositions for identifying and treating patients with small cell lung cancer Sep 19, 2021 Issued
Array ( [id] => 18895612 [patent_doc_number] => 20240011097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE [patent_app_type] => utility [patent_app_number] => 18/248133 [patent_app_country] => US [patent_app_date] => 2021-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248133 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248133
COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE Sep 15, 2021 Pending
Menu